Meeting Banner
Abstract #2473

Hepatobiliary Contrast Uptake Patterns in Liver Metastases from Pancreatic Ductal Adenocarcinoma: Prediction for Patients’ Overall Survival

Yoshifumi Noda1,2, Vinit Baliyan1, Hamed Kordbacheh1, and Avinash R Kambadakone1
1Radiology, Massachusetts General Hospital, Boston, MA, United States, 2Radiology, Gifu University, Gifu, Japan

Gadoxetic acid is a liver-specific contrast agent and has been reported to be useful for the detection of liver metastases in patients with pancreatic ductal adenocarcinoma (PDAC). Recently, aberrant OATP expression has been reported in liver metastases from PDAC and is associated with poor prognosis. Our results show that patients with liver metastases demonstrating heterogeneous hypointensity on hepatobiliary phase images are associated with worse overall survival compared to those with homogeneous hypointensity.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here